IVIg for Demyelination in Diabetes Mellitus

Clinical trial NCT02372149 · UNKNOWN

Trial details

NCT number: NCT02372149
Sponsor: University of Toronto
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Neuropathy Diabetes Mellitus Chronic Inflammatory Demyelinating Polyneuropathy

Start date: 2015-02-01
Primary completion: 2018-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.